CollPlant Biotechnologies Statistics

Total Valuation

CLGN has a market cap or net worth of $39.06 million. The enterprise value is $26.94 million.

Market Cap	39.06M
Enterprise Value	26.94M

Important Dates

The last earnings date was Wednesday, November 27, 2024, before market open.

Earnings Date	Nov 27, 2024
Ex-Dividend Date	n/a

Share Statistics

CLGN has 11.45 million shares outstanding. The number of shares has increased by 1.19% in one year.

Current Share Class	11.45M
Shares Outstanding	11.45M
Shares Change (YoY)	+1.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	30.97%
Owned by Institutions (%)	17.60%
Float	7.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	60.09
Forward PS	2.94
PB Ratio	2.31
P/TBV Ratio	2.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	41.45
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.38, with a Debt / Equity ratio of 0.19.

Current Ratio	5.38
Quick Ratio	5.15
Debt / Equity	0.19
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -70.65% and return on invested capital (ROIC) is -41.19%.

Return on Equity (ROE)	-70.65%
Return on Assets (ROA)	-38.22%
Return on Capital (ROIC)	-41.19%
Revenue Per Employee	$8,667
Profits Per Employee	-$232,267
Employee Count	75
Asset Turnover	0.02
Inventory Turnover	2.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.74% in the last 52 weeks. The beta is 0.51, so CLGN's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-32.74%
50-Day Moving Average	4.04
200-Day Moving Average	4.90
Relative Strength Index (RSI)	30.31
Average Volume (20 Days)	13,831

Short Selling Information

Short Interest	6,728
Short Previous Month	12,072
Short % of Shares Out	0.15%
Short % of Float	n/a
Short Ratio (days to cover)	0.70

Income Statement

In the last 12 months, CLGN had revenue of $650,000 and -$17.42 million in losses. Loss per share was -$1.52.

Revenue	650,000
Gross Profit	-1.48M
Operating Income	-18.35M
Pretax Income	-7.50M
Net Income	-17.42M
EBITDA	-17.27M
EBIT	-18.35M
Loss Per Share	-$1.52

Full Income Statement

Balance Sheet

The company has $15.37 million in cash and $3.25 million in debt, giving a net cash position of $12.12 million or $1.06 per share.

Cash & Cash Equivalents	15.37M
Total Debt	3.25M
Net Cash	12.12M
Net Cash Per Share	$1.06
Equity (Book Value)	16.92M
Book Value Per Share	1.48
Working Capital	13.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.97 million and capital expenditures -$653,000, giving a free cash flow of -$13.63 million.

Operating Cash Flow	-12.97M
Capital Expenditures	-653,000
Free Cash Flow	-13.63M
FCF Per Share	-$1.19

Full Cash Flow Statement

Margins

Gross Margin	-227.08%
Operating Margin	-2,822.31%
Pretax Margin	-2,680.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLGN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.19%
Shareholder Yield	-1.19%
Earnings Yield	-44.60%
FCF Yield	-34.89%

Analyst Forecast

The average price target for CLGN is $12.50, which is 266.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.50
Price Target Difference	266.57%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 21, 2016. It was a reverse split with a ratio of 0.6666666:1.

Last Split Date	Nov 21, 2016
Split Type	Reverse
Split Ratio	0.6666666:1

Scores

CLGN has an Altman Z-Score of -2.15 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.15
Piotroski F-Score	1